Provided by Tiger Trade Technology Pte. Ltd.

Immunome Inc.

19.10
-0.2150-1.11%
Volume:1.16M
Turnover:22.33M
Market Cap:2.17B
PE:-7.68
High:19.56
Open:18.94
Low:18.94
Close:19.31
52wk High:30.06
52wk Low:13.49
Shares:113.58M
Float Shares:108.26M
Volume Ratio:0.82
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4851
EPS(LYR):-2.4315
ROE:-64.03%
ROA:-37.78%
PB:4.13
PE(LYR):-7.85

Loading ...

Pyxis Oncology Q2 Loss Widens on Increased Administrative Costs

Reuters
·
Aug 13

Immunome Director Isaac Barchas Reports Disposal of Common Shares Worth $2.18 Million

Reuters
·
Aug 13

Oncology Device Maker RenovoRx's Q2 Revenue Surges, Raises FY Outlook

Reuters
·
Aug 13

Immunome Price Target Raised to $35.00/Share from $31.00 by Wedbush

Dow Jones
·
Aug 13

Evercore ISI Remains a Buy on Immunome (IMNM)

TIPRANKS
·
Aug 12

Immunome, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)

TIPRANKS
·
Aug 12

Wedbush Adjusts Price Target on Immunome to $35 From $31, Keeps Outperform Rating

MT Newswires Live
·
Aug 12

Piper Sandler Keeps Their Buy Rating on Immunome (IMNM)

TIPRANKS
·
Aug 12

Simris Alg Q2 Ebitda Loss Narrows

Reuters
·
Aug 12

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 12

Oncology Firm Immunome's Q2 Net Loss Widens as R&D Costs Rise

Reuters
·
Aug 12

Immunome Q2 EPS $(0.65) Misses $(0.52) Estimate

Benzinga Earnings
·
Aug 12

Immunome Rugi Bersih Q2 FY26 Melebar Ke USD 73,13 Juta; Revenue Tidak Ada

Reuters
·
Aug 12

Immunome Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 12

Immunome Director Isaac Barchas Reports Disposal of 36,088 Common Shares Worth $940,453.28

Reuters
·
Aug 11

Immunome, Inc. Expected to Post a Loss of 52 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Immunome Chief Business Officer Horn Kinney Sells 90,616 Common Shares for $2.27 Million

Reuters
·
Aug 07

Immunome Grants Inducement Stock Options for 176,500 Shares at $23.01 to New Hires

Reuters
·
Aug 07

Immunome Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 07